Shares of Moderna Inc. /zigman2/quotes/205619834/composite MRNA -4.97% slid 8.85% to $186.61 Tuesday, on what proved to be an all-around poor trading session for the stock market, with the NASDAQ Composite Index /zigman2/quotes/210598365/realtime COMP -0.30% falling 2.60% to 14,506.90 and Dow Jones Industrial Average /zigman2/quotes/210598065/realtime DJIA +0.03% falling 1.51% to 35,368.47. This was the stock's third consecutive day of losses. Moderna Inc. closed $310.88 below its 52-week high ($497.49), which the company reached on August 10th.
The stock underperformed when compared to some of its competitors Tuesday, as AbbVie Inc. /zigman2/quotes/202428675/composite ABBV -0.47% rose 0.67% to $136.78, Amgen Inc. /zigman2/quotes/209157011/composite AMGN +1.12% fell 0.65% to $233.83, and AstraZeneca PLC ADR /zigman2/quotes/200304487/composite AZN +2.59% rose 1.68% to $59.84. Trading volume (10.9 M) remained 1.3 million below its 50-day average volume of 12.2 M.